Group 1 - The core point of the article is that Xilong Science has been recognized as a specialized and innovative small and medium-sized enterprise in Sichuan Province, which is valid from October 23, 2025, to October 31, 2028 [1] - Xilong Science's revenue composition for the first half of 2025 shows that the chemical industry accounts for 95.93%, the new energy sector for 3.98%, and the service industry (property rental) for 0.09% [1] - As of the report date, Xilong Science has a market capitalization of 5 billion yuan [2]

Core Insights - On November 10, Xilong Science executed a block trade of 270,000 shares, amounting to 2.0682 million yuan, which represented 1.4% of the total trading volume for the day. The transaction price was 7.66 yuan, reflecting a discount of 10.41% compared to the market closing price of 8.55 yuan [1][2]. Summary by Category - **Transaction Details** - Date of transaction: November 10, 2025 - Security code: 002584 - Security name: Xilong Science - Transaction price: 7.66 yuan - Transaction volume: 270,000 shares - Transaction amount: 2.0682 million yuan [2]. - **Brokerage Information** - Buyer brokerage: Changjiang Securities Co., Ltd., Beijing Million Street Securities Department - Seller brokerage: Guolian Minsheng Securities Co., Ltd., Guangzhou Huaxia Road Securities Department [2].

Core Viewpoint - Xilong Science Co., Ltd. has been recognized as a specialized and innovative small and medium-sized enterprise in Sichuan Province for the year 2025, with the certification valid from October 23, 2025, to October 31, 2028 [1] Company Summary - Xilong Science's wholly-owned subsidiary, Sichuan Xilong Science Co., Ltd., has been included in the list of newly recognized and re-evaluated specialized and innovative small and medium-sized enterprises by the Sichuan Provincial Economic and Information Technology Department [1]

根据四川省经济和信息化厅发布的《关于 2025 年度四川省专精特新中小企业 新认定及通过复核企业名单的公告》（2025 年第 58 号），西陇科学股份有限公司 （以下简称"公司"）全资子公司四川西陇科学有限公司（以下简称"四川西陇"） 入选 2025 年度四川省专精特新中小企业，有效期为 2025 年 10 月 23 日至 2028 年 10 月 31 日。 二、对公司的影响 "专精特新"中小企业是指具备"专业化、精细化、特色化、新颖化"特征的中 小企业，在产品、技术、管理、模式等方面创新能力强、专注细分市场、成长性 好，是优质中小企业的中坚力量。此次四川西陇入选"专精特新"中小企业是对四 川西陇在技术创新、产品服务和发展前景等方面的认可与肯定，四川西陇作为公 司四大生产基地之一，深耕自主创新研发，以客户需求为核心导向，将坚持"专精 特新"主旨，明确目标，聚焦主业，为实体经济发展作出更大的贡献。 证券代码：002584 证券简称：西陇科学 公告编号：2025-057 西陇科学股份有限公司 关于全资子公司入选四川省专精特新中小企业的自愿性信息披 露公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， ...

西陇科学股份有限公司 关于投资者诉讼事项的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 证券代码：002584 证券简称：西陇科学 公告编号：2025-056 特别提示： 1、案件所处的诉讼阶段：终审。 2、上市公司所处的当事人地位：上诉人（一审被告）。 3、涉案金额：自二审裁定书送达之日起，一审判决发生法律效力。一审判 决书确定的公司赔付金额为 757.01 万元（不含诉讼费等相关费用）。 4、对上市公司损益产生的影响：公司根据一审判决情况对上述已收到法院 传票和/或已开庭的证券虚假陈述责任纠纷案件在《2024 年年度报告》中计提了 预计负债 1,311.31 万元，根据本次裁定书确定的赔偿金额预估，公司计提的预计 负债金额可以覆盖上述所有相关案件可能给公司带来的损失。上述相关投资者诉 讼不会对公司产生重大影响，亦不会对公司的生产经营造成不利影响。 西陇科学股份有限公司（简称"公司"或"西陇科学"）近日收到广东省高级人 民法院送达的"（2025）粤民终 1735 号《民事裁定书》"，现将有关情况公告如 下： 一、本次诉讼的基本情况 1、本次诉讼的 ...

Core Viewpoint - The stock of Xilong Science experienced a slight increase of 0.83% on November 7, closing at 8.51 yuan, with significant block trades occurring totaling 1.189 million shares and a transaction value of 9.0364 million yuan [1][2]. Summary by Sections Block Trades - Four block trades were executed at a price of 7.60 yuan per share, with a total volume of 118.9 thousand shares and a total transaction value of 903.64 thousand yuan [1]. - Each of the first three trades involved 26.50 thousand shares, with a transaction value of 201.40 thousand yuan and a premium rate of -10.69%, executed by different brokerage firms [1]. - The fourth trade involved 39.50 thousand shares, with a transaction value of 300.20 thousand yuan, maintaining the same premium rate of -10.69% [2]. Recent Trading Activity - Over the past three months, the stock has recorded a total of five block trades, amounting to a cumulative transaction value of 11.0378 million yuan [2]. - In the last five trading days, the stock has seen a cumulative increase of 1.67%, with a net inflow of 7.2923 million yuan from major funds [2].

Core Insights - On November 7, Xilong Science executed a block trade of 1.189 million shares, amounting to 9.0364 million yuan, which represented 5.6% of the total trading volume for the day [1] - The transaction price was 7.6 yuan, reflecting a discount of 10.69% compared to the market closing price of 8.51 yuan [1] Summary by Category - **Transaction Details** - Date of transaction: November 7, 2025 - Security code: 002584 - Security name: Xilong Science - Transaction price: 7.60 yuan - Transaction volume: 118.9 million shares - Transaction amount: 9.0364 million yuan [2] - **Trading Parties** - Major buyers included Guotai Junan Securities and CITIC Securities, with various branches involved in the transactions [2] - The selling party was primarily Guolian Minsheng Securities, with multiple branches participating [2]

Group 1 - The core transaction involved 263,000 shares of Xilong Science, with a total transaction value of 2,001,400 CNY, representing 1.81% of the total trading volume for the day [1][2] - The transaction price was 7.61 CNY per share, which is a discount of 9.83% compared to the market closing price of 8.44 CNY [1][2] - The buyer was from China Merchants Securities Co., Ltd., while the seller was from Guolian Minsheng Securities Co., Ltd. [2]

Group 1 - The restructuring protein concept declined by 1.06%, ranking among the top declines in concept sectors, with *ST WanFang hitting the limit down [1] - Within the restructuring protein sector, major declines were seen in He Yuan Bio, San Sheng Guo Jian, and Hua Xi Bio, while 15 stocks experienced price increases, with InnoTech, Dezheng Health, and Ao Pu Mai leading the gains at 1.72%, 1.36%, and 1.33% respectively [1][2] Group 2 - The restructuring protein sector saw a net outflow of 542 million yuan from main funds, with 33 stocks experiencing outflows, and 13 stocks seeing outflows exceeding 10 million yuan [2] - He Yuan Bio had the highest net outflow of 277 million yuan, followed by Rejing Bio, Hua Xi Bio, and Hua Lan Bio with net outflows of 38.27 million yuan, 34.39 million yuan, and 32.92 million yuan respectively [2][3] Group 3 - The top stocks with net inflows in the restructuring protein sector included Jianyou Co., Xilong Science, and Borui Pharmaceutical, with net inflows of 17.18 million yuan, 13.67 million yuan, and 8.93 million yuan respectively [4]

Core Viewpoint - Xilong Science (002584) announced that neither the company nor its controlling subsidiaries have any overdue guarantees [1] Group 1 - The company confirmed the absence of overdue guarantees, indicating a stable financial position [1]